Bookmark this page — the only place tracking real acceptance speed, FWCI and field-normalized citation data for this journal.

Journal decision profile

Journal of Nanobiotechnology

Engineering · Biochemistry, Genetics and Molecular Biology

BioMed CentralUnited KingdomeISSN 1477-3155

Visit homepage

12.42026 metrics scoreOpenAlex · CC0

106dmedian speedlatest 100 articles

$3,190publishing cost*verify with journal

Journal Metrics Score

Journal Metrics ScoreThe visible value is the 2026Journal Metrics Score: citations in the most recent complete year to the journal's works from the two prior years, divided by the number of those works — from OpenAlex open data (CC0).

2026

12.4

Journal Metrics Score 2026 · 2021–2024 window citedness 14.80.

Speed

SpeedMedian calendar days from manuscript received to accepted. It includes revision time and is not the journal's time to first decision.

PUBMED

106 days

Submission → acceptance · median · 100/100 recent articles.

APC / cost*

APC / cost*Costs are indicative and may exclude taxes, waivers, society discounts, or article-type charges. Always verify the journal's official website.

VERIFY

$3,190

Indicative journal-level APC. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

A visual summary for comparison—not a single black-box star rating.

Relative profile

Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible

Metrics Score

Metrics ScoreThe 2026 Journal Metrics Score, normalized within a comparable journal cohort for this preview.

12.42026 · OPENALEX

Source output rank

Source output rankLifetime journal-wide output rank among OpenAlex sources associated with the journal’s leading topic.

#60 / 640LIFETIME OUTPUT

Highly cited papers

Highly cited papersRecent works in the global top 10% after normalization by work type, year, and subfield.

60.4%FIELD-NORMALIZED TOP 10%

Field-normalized impact

Field-normalized impactMedian FWCI, where 1.0 is the expected citation level for comparable work.

3.22MEDIAN FWCI

Review speed

Review speedMedian submission-to-acceptance time from qualified PubMed records.

106 daysMEDIAN

Recent output

Recent outputAverage annual publication volume across the complete analysis window.

578 / yr2021–2024 AVG

Cost efficiency

Cost efficiencyNo score is assigned without a reliable journal-level cost.

—NOT SCORED

Field-normalized top 10% share60.4%

1396 of 2,311 works · same type, year & subfield

Field-normalized top 1% share9.4%

218 works · same type, year & subfield

Median FWCI3.22×

Above field-year expectation

Source output rank#60

of 640 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 3.22, so its typical recent paper runs about 222% above its field benchmark.

What does Top 10% Share mean?

60.4% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Submission to acceptance time (publication speed)

Among 100 recent articles with complete PubMed dates, the median time from received to accepted was 106 days. It includes revisions and is not the journal's time to first decision.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

822016

922017

1052018

1262019

1772020

4592021

5462022

5032023

8032024

8902025

Recent work-type mix

2,311 OpenAlex works · 2021–2024

Article95.2%

Erratum3.9%

Retraction0.4%

Review0.4%

OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.

Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

NanoparticlesNeoplasmsExosomesExtracellular VesiclesMicroRNAsNanostructuresMesenchymal Stem CellsHydrogelsAntineoplastic Agents

Leading OpenAlex topics

2021–2024 works

Nanoplatforms for cancer theranostics408

Extracellular vesicles in disease248

Nanoparticle-Based Drug Delivery82

Wound Healing and Treatments66

Advanced biosensing and bioanalysis techniques64

Advanced Nanomaterials in Catalysis62

RNA Interference and Gene Delivery62

Nanoparticles: synthesis and applications38

Immunotherapy and Immune Responses36

Bone Tissue Engineering Materials35

Methodology: OpenAlex snapshot 2026-08-09. FWCI, percentile badges, topics, and type mix use 2,311 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.